A comparative phase III clinical study to evaluate efficacy and safety of TrastuRel™ (biosimilar trastuzumab) and innovator trastuzumab in patients with metastatic human epidermal growth factor receptor 2 (HER2)-overexpressing breast cancer
Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer - Annals of Oncology
Herceptin® (trastuzumab) for HER2+ Cancer
Figure 2: Mechanism of Action of Trastuzumab and Pathogenesis of its Cardiotoxicity | Radcliffe Cardiology
Anti-HER2 therapy in metastatic breast cancer: many choices and future directions | SpringerLink
Mechanism of action of T-DM1 Notes: (1) Trastuzumab retains all of its... | Download Scientific Diagram
Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer | British Journal of Cancer
a) Summary of the proposed mechanism(s) of Trastuzumab action. The... | Download Scientific Diagram
![PDF] Trastuzumab--mechanism of action and use in clinical practice. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2b6fa09e891793be5e47cf111902529c62718b1c/2-Figure1-1.png "PDF] Trastuzumab--mechanism of action and use in clinical practice. | Semantic Scholar")
PDF] Trastuzumab--mechanism of action and use in clinical practice. | Semantic Scholar
Trastuzumab emtansine: mechanisms of action and drug resistance | Breast Cancer Research | Full Text
Targeted treatments of HER2-positive metastatic breast cancer: trastuzumab and beyond | Breast Cancer Management
Trastuzumab - Wikipedia
Herceptin: mechanisms of action and resistance - ScienceDirect
Trastuzumab: triumphs and tribulations | Oncogene
Trastuzumab emtansine: the first targeted chemotherapy for treatment of breast cancer | Future Oncology
Overcoming trastuzumab resistance in HER2‐positive breast cancer using combination therapy - Derakhshani - 2020 - Journal of Cellular Physiology - Wiley Online Library
Herceptin® (trastuzumab) for HER2+ Cancer
Enhertu Effective in HER2-Positive Metastatic Breast Cancer - National Cancer Institute
Trastuzumab in the Treatment of Breast Cancer | SpringerLink
Evolving novel anti-HER2 strategies - The Lancet Oncology
Interaction of host immunity with HER2-targeted treatment and tumor heterogeneity in HER2-positive breast cancer | Journal for ImmunoTherapy of Cancer | Full Text
Trastuzumab (Herceptin) | American Journal of Neuroradiology
![HERCEPTIN Herceptin [trastuzumab] Herceptin Small Tumor - ppt download](https://slideplayer.com/slide/4850597/15/images/5/5+mechanisms+of+action+Herceptin+inhibits+proliferation+and.jpg "HERCEPTIN Herceptin [trastuzumab] Herceptin Small Tumor - ppt download")
HERCEPTIN Herceptin [trastuzumab] Herceptin Small Tumor - ppt download
